{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:12:53Z","timestamp":1772165573430,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Michael G. DeGroote National Pain Centre","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain<\/jats:italic>\n                      (COG) was developed in response to increasing rates of opioid-related hospital visits and deaths in Canada, and uncertain benefits of opioids for chronic non-cancer pain (CNCP). Following publication, we developed a list of evaluable outcomes to assess the impact of this guideline on practice and patient outcomes\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A working group at the National Pain Centre at McMaster University used a modified Delphi process to construct a list of clinical and patient outcomes important in assessing the uptake and application of the COG. An advisory group then reviewed this list to determine the relevance and feasibility of each outcome, and identified potential data sources. This feedback was reviewed by the National Faculty for the Guideline, and a National Advisory Group that included the creators of the COG, resulting in the final list of 5 priority outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five outcomes were judged clinically important and feasible to measure: 1) Effects of opioids for CNCP on quality of life, 2) Assessment of patient\u2019s risk of addiction before starting opioid therapy, 3) Monitoring patients on opioid therapy for aberrant drug-related behaviour, 4) Mortality rates associated with prescription opioid overdose and 5) Use of treatment agreements with patients before initiating opioid therapy for CNCP. Data sources for these outcomes included patient\u2019s medical charts, e-Opioid Manager, prescription monitoring programs and administrative databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Measuring the impact of best practice guidelines is infrequently done. Future research should consider capturing the five outcomes identified in this study to evaluate the impact of the COG in promoting evidence-based use of opioids for CNCP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-020-0930-4","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T06:06:26Z","timestamp":1578377186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying appropriate outcomes to help evaluate the impact of the Canadian Guideline for Safe and Effective Use of Opioids for Non-Cancer Pain"],"prefix":"10.1186","volume":"20","author":[{"given":"Michael","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Sproule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Borg Debono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-6813","authenticated-orcid":false,"given":"Norman","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"930_CR1","unstructured":"Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. [ http:\/\/nationalpaincentre.mcmaster.ca\/opioid\/]."},{"issue":"18","key":"930_CR2","doi-asserted-by":"publisher","first-page":"E659","DOI":"10.1503\/cmaj.170363","volume":"189","author":"JW Busse","year":"2017","unstructured":"Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, Agoritsas T, Akl EA, Carrasco-Labra A, Cooper L. Guideline for opioid therapy and chronic noncancer pain. Can Med Assoc J. 2017;189(18):E659\u201366.","journal-title":"Can Med Assoc J"},{"key":"930_CR3","unstructured":"National Pain Centre, Guidelines [http:\/\/nationalpaincentre.mcmaster.ca\/guidelines.html]."},{"key":"930_CR4","unstructured":"The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain [http:\/\/nationalpaincentre.mcmaster.ca\/guidelines.html]."},{"key":"930_CR5","unstructured":"Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. Appendix A-1 [http:\/\/nationalpaincentre.mcmaster.ca\/opioid\/cgop_a_app_a01.html]."},{"issue":"9","key":"930_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1503\/cmaj.100187","volume":"182","author":"AD Furlan","year":"2010","unstructured":"Furlan AD, Reardon R, Weppler C. National Opioid use Guideline G: opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ. 2010;182(9):923\u201330.","journal-title":"CMAJ"},{"issue":"11","key":"930_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.7326\/0003-4819-154-11-201106070-00011","volume":"154","author":"C Laine","year":"2011","unstructured":"Laine C, Taichman DB, Mulrow C. Trustworthy clinical guidelines. Ann Intern Med. 2011;154(11):774\u20135.","journal-title":"Ann Intern Med"},{"issue":"1","key":"930_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/chp.20001","volume":"29","author":"DE Moore Jr","year":"2009","unstructured":"Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Heal Prof. 2009;29(1):1\u201315.","journal-title":"J Contin Educ Heal Prof"},{"issue":"6","key":"930_CR9","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.3109\/0142159X.2011.575903","volume":"33","author":"R Penciner","year":"2011","unstructured":"Penciner R, Langhan T, Lee R, Mcewen J, Woods RA, Bandiera G. Using a Delphi process to establish consensus on emergency medicine clerkship competencies. Medical teacher. 2011;33(6):e333\u20139.","journal-title":"Medical teacher"},{"issue":"1","key":"930_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NCC.0b013e318210e3a2","volume":"35","author":"EP Uphoff","year":"2012","unstructured":"Uphoff EP, Wennekes L, Punt CJ, Grol RP, Wollersheim HC, Hermens RP, Ottevanger PB. Development of generic quality indicators for patient-centered cancer care by using a RAND modified Delphi method. Cancer Nurs. 2012;35(1):29\u201337.","journal-title":"Cancer Nurs"},{"issue":"7","key":"930_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0828-282X(06)70276-8","volume":"22","author":"N Campbell","year":"2006","unstructured":"Campbell N, Onysko J. Canadian hypertension education P, outcomes research task F: the outcomes research task Force and the Canadian hypertension education program. Can J Cardiol. 2006;22(7):556\u20138.","journal-title":"Can J Cardiol"},{"key":"930_CR12","unstructured":"Hypertension Canada [https:\/\/hypertension.ca\/]."},{"key":"930_CR13","unstructured":"Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain - Part B: Recommendations for Practice [http:\/\/nationalpaincentre.mcmaster.ca\/documents\/opioid_guideline_part_b_v5_6.pdf]."},{"key":"930_CR14","unstructured":"Hosted survey solutions [http:\/\/objectplanet.com\/opinio\/hosted-survey-solution.html]."},{"key":"930_CR15","unstructured":"Nova Scota Department of Health and Wellness. Hypertension Indicator Priority Setting Tool. Halifax, Nova Scotia: The Department of Health and Wellness; 2012."},{"key":"930_CR16","unstructured":"Centre for Effective Practice [https:\/\/effectivepractice.org\/]."},{"key":"930_CR17","unstructured":"Opioid Manager [https:\/\/www.opioidmanager.com\/]."},{"key":"930_CR18","unstructured":"Opioid Manager [http:\/\/nationalpaincentre.mcmaster.ca\/opioidmanager\/]."},{"issue":"4","key":"930_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1526-4637.2003.03040.x","volume":"4","author":"TE Elliott","year":"2003","unstructured":"Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003;4(4):331\u20139.","journal-title":"Pain Med"},{"key":"930_CR20","volume-title":"Chronic pain in Canada: laying the Foundation for Action","author":"CPT Force","year":"2019","unstructured":"Force CPT. Chronic pain in Canada: laying the Foundation for Action. Canada: Health Canada; 2019."},{"key":"930_CR21","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.drugalcdep.2016.08.641","volume":"173","author":"KS Barth","year":"2017","unstructured":"Barth KS, Guille C, McCauley J, Brady KT. Targeting practitioners: a review of guidelines, training, and policy in pain management. Drug Alcohol Depend. 2017;173:S22\u201330.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"930_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1503\/cmaj.121830","volume":"185","author":"A Chatterjee","year":"2013","unstructured":"Chatterjee A, Bhattacharyya O, Persaud N. How can Canadian guideline recommendations be tested? Cmaj. 2013;185(6):465\u20137.","journal-title":"Cmaj"},{"key":"930_CR23","doi-asserted-by":"publisher","first-page":"410754","DOI":"10.4061\/2011\/410754","volume":"2011","author":"P Bolli","year":"2011","unstructured":"Bolli P, Campbell NR. Do recommendations for the management of hypertension improve cardiovascular outcome? The canadian experience. Int J Hypertens. 2011;2011:410754.","journal-title":"Int J Hypertens"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-020-0930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-020-0930-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-020-0930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T19:10:43Z","timestamp":1609873843000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-020-0930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1186\/s12871-020-0930-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.9200\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9200\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9200\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}